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Abstract
Background: The transcription factor NFAT5 is a major inducer of osmoprotective genes and is required to maintain the
proliferative capacity of cells exposed to hypertonic stress. In response to hypertonicity, NFAT5 translocates to the nucleus,
binds to regulatory regions of osmoprotective genes and activates their transcription. Besides stimulus-specific regulatory
mechanisms, the activity of transcription factors in cycling cells is also regulated by the passage through mitosis, when most
transcriptional processes are downregulated. It was not known whether mitosis could be a point of control for NFAT5.
Methodology/Principal Findings: Using confocal microscopy we observed that NFAT5 was excluded from chromatin
during mitosis in both isotonic and hypertonic conditions. Analysis of NFAT5 deletions showed that exclusion was mediated
by the carboxy-terminal domain (CTD). NFAT5 mutants lacking this domain showed constitutive binding to mitotic
chromatin independent of tonicity, which caused them to localize in the nucleus and remain bound to chromatin in the
subsequent interphase without hypertonic stimulation. We analyzed the contribution of the CTD, DNA binding, and nuclear
import and export signals to the subcellular localization of this factor. Our results indicated that cytoplasmic localization of
NFAT5 in isotonic conditions required both the exclusion from mitotic DNA and active nuclear export in interphase. Finally,
we identified several regions within the CTD of NFAT5, some of them overlapping with transactivation domains, which were
separately capable of causing its exclusion from mitotic chromatin.
Conclusions/Significance: Our results reveal a multipart mechanism regulating the subcellular localization of NFAT5. The
transactivating module of NFAT5 switches its function from an stimulus-specific activator of transcription in interphase to an
stimulus-independent repressor of binding to DNA in mitosis. This mechanism, together with export signals acting in
interphase, resets the cytoplasmic localization of NFAT5 and prevents its nuclear accumulation and association with DNA in
the absence of hypertonic stress.
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Introduction
NFAT5 is a transcription factor that belongs to the Rel family
(NFAT and NF-kB) [1,2]. Its DNA-binding domain is considered a
hybrid between that of NFAT and NF-kB proteins, since it binds
NFAT-like DNA elements [3] but also conserves the molecular
mechanism that mediates dimerization in NF-kB proteins [4–6].
NFAT5 regulates the adaptation of mammalian cells to hypertonic
stress by inducing the expression of osmoprotective gene products
that includechaperones and a number of enzymes and transporters,
such as aldose reductase (AR), whose collective function is to
increase the intracellular concentration of compatible organic
osmolytes that allow cells to adapt and survive in a hypertonic
environment [7,8]. In this regard, NFAT5-deficient mice suffer a
progressive atrophy of their kidney medulla due to an insufficient
expression of osmoprotective gene products and NFAT5-deficient
cells have reduced proliferative capacity and defective expression of
cyclins when cultured in hypertonic media [9,10–12]. In addition,
NFAT5 regulates other processes independently of osmotic stress
responses, such as replication of HIV in macrophages, and
migration of carcinoma or myoblast cells [13–16].
Activation of NFAT5 by hypertonicity involves different layers of
regulation that include its rapid nuclear translocation, induction of
its transcriptional activity, and its enhanced synthesis to provide
additionalamplification oftheosmoprotectiveresponse(reviewedin
[2,17]). Previous work by us and others has shown that NFAT5
contains three major functional regions: a Rel-like DNA-binding
domain(DBD) flankedbya shortamino-terminalregionand a large
carboxy-terminal domain [5]. The nfat5 gene encodes three
isoforms, NFAT5a, b and c, which have identical amino acid
composition except in their respective amino termini. The longest
isoform is NFATc, with 76 additional amino acids before the first
PLoS ONE | www.plosone.org 1 September 2009 | Volume 4 | Issue 9 | e7036methionine of isoform NFAT5a, whichis theshortest [4]. The DBD
confers DNA-binding specificity and also contains the dimerization
surface that makes NFAT5 a constitutive homodimer [3,5,6]. The
carboxy-terminal domain, which is acidic and glutamine-rich, spans
more than 900 amino acids and is responsible for its hypertonicity-
induced transcriptional activity [5,18]. Nucleo-cytoplasmic traffick-
ing of NFAT5 is regulated by sequences located within its amino-
terminal region, preceding the Rel-like DNA-binding domain. In
isotonic conditions, NFAT5 can be found in the cytoplasm or
distributed in both the cytosol and the nucleus [5,19], whereas in
response to hypertonic stress it accumulates in the nucleus, binds to
regulatory regions in target genes, and activates their transcription
[5,19]. Nuclear translocation of NFAT5 in response to hypertonic-
ity is mediated by a nuclear localization sequence (NLS) common to
the three NFAT5 isoforms [20], whereas its export in the absence of
hypertonic stress is regulated by two distinct motifs, a CRM1-
dependent nuclear export signal (NES) found only in the long
isoform NFAT5c, and a CRM1-independent, CK1-regulated,
auxiliary export domain (AED) found in the three isoforms [20–22].
Besides stimulus-specific regulation, transcriptional processes in
proliferating cells are subjected to another layer of control imposed
by mitosis. It is well established that transcriptional silencing during
mitosis is a process that inactivates the basal transcription
machinery, specific transcription factors, and chromatin structural
proteins [23,24]. This event is not governed by a universal
mechanism, but rather the exclusion of individual transcription
factors from mitotic chromatin can be regulated by distinct means.
Examples of transcription factors that are inactivated during mitosis
are the large family of C2H2 zinc fingers and the POU family of
homeodomain proteins [25–27]. These regulatory mechanisms
could serve to inactivate specific proteins during mitosis, but can
also be considered as a window in the cell cycle for resetting
transcriptional programs [28]. In this regard, mitosis can provide
cells with a mechanism to shut down transcriptional processes that
will no longer be needed in the next cell cycle, unless the triggering
stimulus still persists. In a population of cycling cells exposed to a
sustained source of stress, the equilibrium between resetting and
reactivating stress-responsive factors must be finely regulated.
In this work, we describe that the subcellular localization of
NFAT5 and its capacity to bind to chromatin are sensitive to the
passage of cells through mitosis. We report that the carboxy-
terminal domain (CTD) of NFAT5 causes its exclusion from
mitotic chromatin in both isotonic and hypertonic conditions.
NFAT5 mutants lacking this domain bound to mitotic chromatin,
which in turn caused both their constitutive nuclear localization
and association with chromatin in interphase in the absence of
hypertonic stimulation. This regulatory mechanism was observed
in different NFAT5 isoforms. Exclusion from mitotic chromatin
was mediated by different parts of the CTD of NFAT5, some of
which overlapped with transactivation domains. These results
reveal a novel function of the CTD of NFAT5, which, by causing
its dissociation from DNA in mitosis, regulates the subcellular
localization and chromatin association of this protein in inter-
phase. Therefore, our findings indicate that the mitotic resetting of
NFAT5 contributes to ensure that its nuclear localization and
binding to chromatin in the next cell cycle are induced in a
stimulus-specific manner.
Results
The carboxy-terminal domain (CTD) of NFAT5 prevents
its association with mitotic chromatin
As the distribution of many chromatin-binding proteins during
mitosis can be readily visualized using cell imaging techniques by
their exclusion from condensed chromatin between prophase and
telophase [24], our first approach consisted on analyzing whether
NFAT5 was retained on, or excluded from, mitotic chromatin in
cells growing in isotonic or hypertonic conditions. Confocal laser
microscopy analysis of endogenous NFAT5 in HEK293 cells
showed that it had a variable nucleo-cytoplasmic distribution in
individual cells in asynchronous cultures in isotonic media (290–
310 mOsm/kg) and accumulated in the nucleus in response to
hypertonicity (470 mOsm/kg) (Figure 1A). The same experiment
indicated that NFAT5 was excluded from mitotic chromatin in
both isotonic and hypertonic conditions, despite that this stimulus
induced a substantial nuclear accumulation of NFAT5 (Figure 1A)
and, as will be shown later, its recruitment to chromatin in
interphase. Next, we determined the regions of NFAT5 involved
in the exclusion from mitotic chromatin (Figure 1B). GFP-tagged
full-length NFAT5 (isoform a, FL5) [4] exhibited the same
behaviour as the endogenous protein in HEK293 cells, being
excluded from mitotic chromatin regardless of hypertonic
stimulation (Figures 1C, 2 and Figure S1). However, NFAT5
constructs ND5 and DBD5, which lacked the carboxy-terminal
domain (CTD), were constitutively associated with mitotic
chromatin in either isotonic (290–310 mOsm/kg) or hypertonic
conditions (470 mOsm/kg) (Figures 1C, 2 and Figure S1), and the
CTD was sufficient to prevent the association of the DBD with
mitotic chromatin (DBDC5 construct in Figure S1). The same
result was observed in an independent cell line, U2OS (Figure S1).
These results showed that the CTD of NFAT5 caused its exclusion
from mitotic chromatin.
These experiments also revealed that NFAT5 constructs that
bound to mitotic chromatin (ND5 and DBD5) were noticeably
more nuclear than full-length NFAT5 in interphase in isotonic
conditions (290–310 mOsm/kg) (Figure 2 and Figure S2A). This
was particularly intriguing for the DBD5-GFP construct, since it
lacks import signals [20,22] and is structured as a dimer [5] whose
predicted molecular weight as a GFP fusion is 118 kDa, so it
would not be expected to diffuse through the nuclear pore. In view
of these results we analyzed whether the binding to mitotic
chromatin of NFAT5 mutants lacking the CTD could influence
their nucleo-cytoplasmic distribution in interphase in the absence
of hypertonic stress.
Binding of NFAT5 mutants lacking the CTD to DNA in
mitosis causes their constitutive nuclear localization and
association with chromatin in interphase
Mutation of the critical DNA contact residues Thr222, Glu223
andArg226ofNFAT5atoalanine(ND5
DB1andDBD5
DB1mutants)
[5] prevented the association of ND5 and DBD5 with mitotic
chromatin (Figure 3A) and caused them to become cytoplasmic in
interphase in isotonic conditions (Figure 3B). This result indicated
that the association of ND5 and DBD5 with mitotic chromatin was
due to their direct binding to specific NFAT5-recognized DNA
elements. Both FL5 and ND5 DNA binding mutants (FL5
DB1 and
ND5
DB1), which were comparably cytoplasmic in isotonic condi-
tions, could translocate to the nucleus completely in response to
hypertonicity (Figure 3B). In contrast, the subcellular localization of
DBD5 was entirely dependent on its ability to bind DNA and
insensitive to tonicity (see comparison of DBD5 and DBD5
DB1 in
Figures 3B and Figure S2B). Since this domain lacked import and
exportsignals,we hypothesized thatits accesstoDNAcould occurin
mitosis, and that the formation of the nuclear envelope after mitosis
would keep it trapped in the nucleus in the subsequent interphase.
To test this, we expressed the DBD5 in HEK293 and U2OS cells
and, immediately after transfection, treated them with 2-hydroxy-
urea to cause their arrest at the G1/S transition so that they would
Resetting of NFAT5 in Mitosis
PLoS ONE | www.plosone.org 2 September 2009 | Volume 4 | Issue 9 | e7036Figure 1. Displacement of NFAT5 from mitotic chromatin. (A) Endogenous NFAT5 was detected with an antibody specific for its DNA binding
domain and visualized by immunofluorescence and confocal laser microscopy in asynchronous cultures of HEK293 cells after a fresh change of media
to either isotonic conditions (290 or 310 mOsm/kg, 6 hours) or hypertonic conditions (470 mOsm/kg, 4 and 6 hours). Pictures at lower magnification
show a general view of the culture, and higher magnification images display individual mitotic cells (marked by arrowheads). Scale bar is 20 mm. (B)
Schematic representation of NFAT5a constructs FL5, ND5, DBD5 and DBDC5, and the position of their respective tags: FL5, ND5 and DBDC5 were
tagged with 6 copies of a Myc epitope at their amino terminus and GFP at their carboxy terminus. DBD5 was tagged with GFP at its amino terminus.
Constructs were expressed in HEK293 cells and detected by Western blotting with anti-Myc antibody (FL5, ND5 and DBDC5) or anti-GFP antibody
(DBD5). (C) Representative confocal microscopy images of mitotic cells in asynchronous cultures of HEK293 cells expressing the indicated GFP-tagged
constructs in isotonic conditions (310 mOsm/kg) or after a 6-hour exposure to hypertonic conditions (470 mOsm/kg).
doi:10.1371/journal.pone.0007036.g001
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PLoS ONE | www.plosone.org 3 September 2009 | Volume 4 | Issue 9 | e7036not transittomitosis(Figure 3C).Stalling ofcellsinG1precluded the
nuclear localization of the DBD5 in HEK293 and U2OS cells
(Figure 3C), supporting the interpretation that binding to mitotic
chromatin was necessary for its nuclear retention later in interphase.
A summary of the results on nucleo-cytoplasmic localization of FL5,
ND5, DBD5 and their corresponding DNA-binding mutants in
Figure 2. Effect of the carboxy-terminal domain (CTD) on the association of NFAT5a with mitotic chromatin and its subcellular
distribution in interphase. GFP-tagged constructs FL5, ND5 or DBD5 were expressed in HEK293 cells. Their subcellular distribution in interphase
and association with mitotic chromatin in isotonic (290 or 310 mOsm/kg, 6 hours) and hypertonic conditions (470 mOsm/kg, 4 and 6 hours) was
analyzed by confocal microscopy. Scale bar is 20 mm. Results shown are representative of three independent experiments.
doi:10.1371/journal.pone.0007036.g002
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PLoS ONE | www.plosone.org 4 September 2009 | Volume 4 | Issue 9 | e7036Figure 3. Association of the DNA binding domain of NFAT5 with mitotic chromatin is mediated by specific binding to DNA. (A)
Confocal microscopy images of mitotic HEK293 cells expressing the DNA-binding mutant version (DB1) of different NFAT5a deletions tagged with
GFP. Cells were grown in isotonic medium (310 mOsm/kg) or exposed to hypertonic conditions (470 mOsm/kg) during 6 hours. Scale bar is 20 mm.
(B) Subcellular distribution of NFAT5a constructs capable of DNA binding (FL5, ND5, DBD5) or their respective DNA-binding mutants (FL5
DB1, ND5
DB1,
DBD5
DB1) in interphase HEK293 cells cultured in isotonic medium (310 mOsm/kg) or hypertonic conditions (470 mOsm/kg, 4 hours). Scale bar is
20 mm. Results are representative of four independent experiments. (C) HEK293 or U2OS cells transfected with GFP-tagged DBD5 were either left
untreated or treated with 2-hydroxyurea during 48 hours to maintain them arrested in G1/S. Flow cytometry histograms show the cell cycle arrest in
2-hydroxyurea-treated HEK293 cells. Confocal microscopy images show the subcellular distribution of DBD5 in HEK293 and U2OS cells either left
untreated or arrested with 2 mM 2-hydroxyurea (2-HU). Scale bar is 20 mm. The results shown are representative of four independent experiments.
doi:10.1371/journal.pone.0007036.g003
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results indicated that the constitutive nuclear localization of NFAT5
mutants lacking the CTD was due to their specific binding to DNA
in mitosis.
Since the ND5 construct bound mitotic chromatin and was
nuclear in interphase in isotonic conditions, we asked whether this
protein was also constitutively bound to interphase chromatin. We
used chromatin fractionation assays in asynchronously growing
HEK293 cells transfected with full-length NFAT5 or ND5. The
large majority (.97%) of cells in asynchronous HEK293 cultures
were in interphase, as determined by simultaneous analysis of
phosphorylated (S10) histone H3 (indicative of mitotic cells) and
DNA content by flow cytometry (Figure 5A). We observed that
only a small proportion of endogenous NFAT5 was associated
with chromatin in cells growing in isotonic medium, but was
recruited to chromatin upon hypertonic stimulation (Figure 5B).
The fractionation was verified by the detection of pyruvate kinase
only in the soluble fraction and histone H3 only in the chromatin
fraction. Treatment of the lysate with DNase I before extracting
the chromatin removed NFAT5 entirely from this fraction,
confirming its specific association with DNA (Figure 5B). In this
type of assay, transfected full-length NFAT5a (FL5) behaved as the
endogenous protein, being found in the soluble fraction in isotonic
conditions and bound to chromatin upon hypertonic stimulation
(Figure 5C). Recruitment of NFAT5a to chromatin was eliminated
by mutation of its DNA-binding residues (FL5
DB1 and ND5
DB1
mutants in Figure 5C), indicating that chromatin-associated
NFAT5 was specifically bound to its target DNA sites. In contrast
to full-length NFAT5, ND5 was already bound to chromatin in
asynchronous cultures in isotonic conditions, but still could
increase its association with chromatin under hypertonic stress
(Figure 5C). These results indicated that the CTD caused the
exclusion of NFAT5 from chromatin specifically in mitosis, but did
not inhibit its binding to chromatin in response to hypertonicity in
interphase.
Contribution of the carboxy-terminal domain (CTD) and
import/export signals in the amino-terminal region of
NFAT5 to its subcellular localization in isotonic and
hypertonic conditions
The results described above indicated that dissociation of
NFAT5 from mitotic DNA could influence the equilibrium
between nuclear import and export mechanisms in interphase.
We examined the relative contribution of import, export and DNA
binding to the subcellular localization of NFAT5 in isotonic
conditions. These experiments, as those in previous figures, were
done with isoform NFAT5a, which has a nuclear localization
sequence (NLS) and an auxiliary export domain (AED), but lacks
the nuclear export signal (NES) exclusive of the longer isoform
NFAT5c [20]. Mutation of the NLS impaired the translocation of
full length NFAT5a in response to hypertonicity, whereas removal
of its AED caused it to localize in the nucleus in isotonic conditions
(Figure 6A), indicating that the NLS and AED were sufficient to
control the nucleo-cytoplasmic transport of NFAT5a in isotonic or
hypertonic conditions. However, since full-length NFAT5a was
naturally excluded from mitotic chromatin (Figures 1C and 2), we
tested the effect of the NLS and AED mutations in the ND5
construct to take into account the specific contribution of mitotic
DNA binding on import and export in interphase. We then
observed that the NLS mutant was cytoplasmic and unable to
translocate in response to hypertonicity, whereas the AED mutant
was constitutively nuclear in isotonic conditions (Figure 6B). Both
mutants were capable of binding to mitotic chromatin (Figure S3).
The result that inactivating the NLS of ND5 suppressed its nuclear
localization in isotonic conditions was intriguing, since in view of
our previous results (Figures 1C and 2) we would have expected
that this mutant (ND5
NLS) should have been retained to some
extent in the nucleus due to its ability to associate with chromatin
during mitosis. These results suggested that the nuclear retention
of ND5 in isotonic conditions was due to both its binding to
chromatin during mitosis and nuclear import in interphase, and
that lack of either allowed the AED to become dominant and
cause its export. Consistent with this, a double mutant lacking both
the NLS and AED (ND5
NLS+AED) displayed a pancellular
distribution in interphase, which was dependent only on its
DNA binding capacity and was insensitive to hypertonicity
(comparison between ND5
NLS+AED and ND5
DB1+NLS+AED in
Figure 6B and Figure S3). These results indicated that both the
NLS and AED of NFAT5a were active in isotonic conditions, and
that the CTD-mediated exclusion from mitotic chromatin was
required to shift its export/import balance towards a cytoplasmic
localization.
Until here, we had used constructs corresponding to isoform
NFAT5a. Three mRNA isoforms of NFAT5 have been described,
all of which encode predicted proteins that are identical along
1455 amino acids and they only differ in that NFAT5b has 29
extra amino acids in its amino-terminus with respect to the shorter
NFAT5a, and isoform NFAT5c is 47 amino acids longer than
NFAT5b and 76 amino acids longer than NFAT5a [4]. A distinct
feature of isoform NFAT5c is that it has a CRM1-dependent
canonical nuclear export signal (NES) in its first 15 amino acids,
which is absent from isoforms a and b [20]. At present it is
unknown whether all isoforms are expressed as proteins in
different cell types. To detect the potential presence of various
protein isoforms we prepared lysates of several cell types and did
Western blot with an antibody specific for the carboxy terminus,
which is common to all three isoforms. As controls, we used lysates
of HEK293 cells transfected with NFAT5a or NFAT5c constructs
tagged with 3 copies of an HA epitope, which added 38 amino
Figure 4. Subcellular distribution of NFAT5a constructs.
Summary of subcellular localization analyses of the indicated NFAT5a
constructs in interphase HEK293 cells cultured in isotonic medium
(310 mOsm/kg) or exposed to hypertonic conditions (470 mOsm/kg,
4 hours). At least 150 cells with similar GFP fluorescence intensity were
counted for each transfected construct in each assay. Results are the
mean6SD of three independent experiments.
doi:10.1371/journal.pone.0007036.g004
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antibody detected a single band in SDS-polyacrylamide gels of
lysates of HEK293, U2OS, HeLa and mouse embryo fibroblasts
(MEFs) (Figure 7A). The mobility of endogenous NFAT5 in
HEK293 was faster than that of the recombinant HA-NFAT5a
expressed in the same cell line and clearly faster than that of HA-
NFAT5c (Figure 7A). Similarly, endogenous NFAT5 in the other
cell lines (U2OS, HeLa, MEFs) migrated faster than HA-NFAT5a
and HA-NFAT5c. Hence, this experiment suggested that the
predominant isform in them corresponded to NFAT5a. Nonethe-
less, we analyzed whether the long NFAT5c isoform also exhibited
a CTD-dependent regulation of its subcellular localization
in interphase. Full-length NFAT5c (FL5c) expressed in HEK293
cells was predominantly cytosolic in isotonic medium (290–
310 mOsm/kg) and completely nuclear in hypertonic conditions
(470 mOsm/kg) (Figure 7B and Figure S4). NFAT5c was also
excluded from mitotic chromatin in isotonic as well as hypertonic
conditions, and removal of its CTD caused it to bind mitotic
chromatin (ND5c, Figure 7B and Figure S4). ND5c was more
accumulated in the nucleus than full length NFAT5c or NFAT5a
in isotonic conditions (290–310 mOsm/kg) (Figure 7B and Figure
S4), which suggested that the NES and AED were not sufficient to
ensure a complete cytoplasmic localization of an NFAT5c
construct lacking the CTD. This observation was in agreement
with experiments by Tong et al. using a similar NFAT5c deletion,
which showed an appreciable degree of nuclear localization in
isotonic medium, although it became cytoplasmic under hypotonic
conditions [20]. The nuclear accumulation of ND5c in isotonic
Figure 5. Constitutive binding to interphase chromatin of an NFAT5a mutant lacking the CTD. (A) Flow cytometry analysis of the cell
cycle profile (left histogram) and proportion of interphase and mitotic cells (dot plot) in asynchronous HEK293 cultures. (B) HEK293 cells cultured in
isotonic medium (310 mOsm/kg) or exposed to hypertonic conditions (470 mOsm/kg) during 4 hours were lysed and proteins were fractionated into
soluble (S) or chromatin (Ch) fractions. One set of samples was treated with DNase I during lysis, which caused the release of chromatin-associated
proteins to the soluble fraction. NFAT5 and markers of soluble (pyruvate kinase) and chromatin-associated proteins (histone H3) were detected by
Western blotting. (C) HEK293 cells expressing Myc-tagged full length NFAT5a (FL5), a DNA-binding mutant (FL5
DB1), or a construct comprising the
amino-terminal region plus DNA-binding domain (ND5) (diagram in Figure 1B) and its DNA-binding mutant (ND5
DB1) were cultured in isotonic
medium (290 mOsm/kg) or exposed to hypertonic conditions (470 mOsm/kg) during 4 hours, lysed, and proteins were fractionated into soluble (S)
or chromatin (Ch) fractions. NFAT5 constructs were detected by Western blotting with an anti-Myc antibody. Results shown are representative of four
independent experiments.
doi:10.1371/journal.pone.0007036.g005
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PLoS ONE | www.plosone.org 7 September 2009 | Volume 4 | Issue 9 | e7036Figure 6. Regulation of the localization of NFAT5a by its CTD, nuclear localization signal (NLS), the auxiliary export domain (AED)
and DNA binding. (A) Confocal microscopy images of HEK293 cells (whole culture or mitotic cells) expressing wild-type NFAT5a (FL5), an NLS
mutant (FL5
NLS), or an AED mutant (FL5
AED). Cells were grown in isotonic medium (310 mOsm/kg) or exposed to hypertonic conditions (470 mOsm/
kg) during 4 hours. Scale bar is 20 mm. (B) Confocal microscopy images of HEK293 cells expressing DNA-binding-competent (upper panel) or DNA-
binding-disabled (DB1, bottom panel) versions of ND5 with intact NLS and AED motifs or with the NLS, AED or both mutated. Cells were grown in
isotonic medium (310 mOsm/kg) or exposed to hypertonic conditions (470 mOsm/kg) during 4 hours. Scale bar is 20 mm. Results shown are
representative of three independent transfections.
doi:10.1371/journal.pone.0007036.g006
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(construct ND5c
DB1) (Figure 7B and Figure S4). Altogether, our
results suggested that the cytoplasmic localization of both NFAT5a
and NFAT5c isoforms in isotonic conditions required the CTD-
mediated exclusion from mitotic chromatin.
Different regions of the carboxy-terminal domain of
NFAT5 mediate its exclusion from mitotic chromatin
We next mapped which regions in the CTD of NFAT5a
mediated its exclusion from mitotic chromatin (Figure 8 and
Figure S5). Two regions encoded by exon 14 were independently
capable of causing a strong exclusion (constructs NFAT5
12838 and
NFAT5
(12473) + (83921377)), whereas the regions encoded by the
short exons 13 and 15 had a milder effect (constructs NFAT5
12547
and NFAT5
(12497) + (137821455)), and the region encoded by exon
12 did not displace NFAT5 from mitotic chromatin (construct
NFAT5
12497) (Figure 8). In parallel, we analyzed the transcrip-
tional activity of these deletion mutants in isotonic and hypertonic
conditions. This analysis was done in mouse embryo fibroblasts
(MEFs) devoid of NFAT5 activity [9], to prevent the contribution
of endogenous NFAT5. The experiments showed that some of the
regions causing the exclusion of NFAT5 from mitotic chromatin
overlapped with transactivation domains, whereas others did not
confer transcriptional activity (Figures 8 and 9). This is respectively
illustrated by constructs NFAT5
(12473)+(83921377) and NFAT5
12838
(Figures 8 and 9). In addition, it was noticeable that among the
mutants spanning different regions of the CTD, none of those able
to bind to mitotic DNA were transcriptionally active whereas those
with transcriptional activity were all excluded from mitotic
chromatin. These results indicated that the CTD of NFAT5
contained two types of regions that could independently cause its
exclusion from mitotic chromatin: those encoded by exons 13, 15
and part of exon 14 were not essential for its transcriptional
activity, whereas the region encoded by the second half of exon 14
had a hypertonicity-activated transcriptional function in inter-
phase that changed to repressing the binding of NFAT5 to
chromatin in mitosis.
Effect of the constitutive nuclear localization of NFAT5 on
its osmoresponsive transcriptional activity
Our previous results raised the question of whether the control of
the cytoplasmic localization of NFAT5 was necessary to prevent the
activation of osmoregulatory responses in the absence of hypertonic
stress. Since none of our mutants was simultaneously able to
associatewith mitoticchromatinand displaytranscriptional activity,
we could not use them to address how binding to DNA in mitosis
affected the transcriptional response to hypertonicity in interphase.
However, since one consequence of the retention of NFAT5
mutants in mitotic chromatin was that they were localized in the
nucleus in the next interphase, we used the alternative approach of
testing whether a constitutively nuclear NFAT5a (export domain
mutant FL5
AED, Figure 6A) had greater basal transcriptional
activity than wild-type NFAT5 in isotonic conditions. These
experiments were done in MEFs lacking NFAT5 activity [9]. We
found that the export mutant was a stronger activator of an
osmoresponsive reporter than wild-type NFAT5 in isotonic
conditions (Figure 10). This effect was observed when low amounts
of NFAT5 were transfected (1.5 or 3 mg DNA/9.4 cm
2 well),
whereas overexpression of either construct produced a similarly
high basal transcriptional response. These results indicated that
enhancing the nuclear accumulation of NFAT5 caused a significant
transcriptional response in isotonic conditions, although hypertonic
stimulation was still required for full induction of its activity.
Discussion
In this work we show that exclusion of NFAT5 from mitotic
chromatin can reset its nucleo-cytoplasmic distribution in
interphase in isotonic conditions. This process is controlled by
the carboxy-terminal domain (CTD) of NFAT5, which contains
several regions independently capable of preventing its association
with mitotic chromatin. The overlapping of some of these regions
with transactivation domains reveals that modules of NFAT5
involved in transcriptional activation in interphase can adopt a
different role during mitosis, and cause the exclusion of NFAT5
from chromatin (Figure 11A). This mechanism, which functions in
different NFAT5 isoforms, contributes to maintain NFAT5 in the
cytosol and prevent its association with chromatin in interphase in
isotonic conditions, indicating that mitosis is a significant point of
control of NFAT5 (Figure 11B).
Our results reveal a previously unappreciated function of the
CTD of NFAT5, and indicate that the control of its nucleo-
cytoplasmic localization in cycling cells resides not only in import
and export sequences located in its amino-terminal region [20,22].
To our knowledge, this would be the first description of a
transcription factor whose transactivation domain switches its
function from an stimulus-specific activator of transcription in
interphase to an stimulus-independent repressor of binding to
DNA in mitosis, a function that serves to reset the nucleo-
cytoplasmic distribution of the factor in the subsequent interphase.
That exclusion of NFAT5 from mitotic DNA also occurred in
hypertonic conditions indicates that binding of this factor to
regulatory regions of osmoprotective genes is subject to associa-
tion/dissociation cycles in proliferating cells and has to be
reactivated after mitosis. This scenario raises the question of
whether NFAT5-dependent osmoprotective genes use bookmark-
ing mechanisms to facilitate their reinduction if cells exiting mitosis
remain exposed to osmotic stress. Gene bookmarking has been
described in the regulatory regions of genes controlled by other
transcription factors that are inactivated during mitosis [28–30].
The relevance of NFAT5 using its carboxy-terminal domain to
dissociate from mitotic chromatin is to ensure that the tonicity-
sensitive import/export mechanisms may accurately control its
subcellular localization and access to chromatin in the next
interphase. This regulation is evident in cycling cells, since the
breakdown of the nuclear envelope barrier in mitosis allows the
access of NFAT5 to DNA, creating the need for preventing it from
remaining bound to chromatin throughout the next interphase.
Exclusion from mitotic chromatin would ensure that the
subcellular localization of NFAT5 in interphase is properly
controlled by nuclear import and export. It can be speculated
that having various independent regulatory mechanisms might
provide a finer control of its function. Although the signals
regulating NFAT5 import/export have not been fully elucidated,
at least one recent report [21] has shown that CK1-mediated
phosphorylation of the AED is important for its export function,
and it is conceivable that other regulators might affect these
processes. Such regulation could be hampered if NFAT5 was
persistently associated with nuclear DNA as result of having been
retained in chromatin during mitosis. It is also possible that
sustained activity of this factor due to uncontrolled nuclear
localization might be detrimental for the cell. For instance, it has
been reported that overaccumulation of organic osmolytes in cells
not subjected to osmotic stress can be toxic [31–33], and thus
limiting NFAT5 activity in the absence of stress might help to
prevent such negative effects. In this regard, our comparison of a
wild-type NFAT5 construct with a constitutively nuclear one
suggested that nuclear localization alone without hypertonicity
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PLoS ONE | www.plosone.org 9 September 2009 | Volume 4 | Issue 9 | e7036Figure 7. Association with mitotic chromatin and subcellular localization of an NFAT5c mutant lacking its CTD. (A) Comparison of the
relative mass of endogenous NFAT5 in different cell lines. HA-tagged NFAT5c and HA-tagged NFAT5a expressed in HEK293 cells, or endogenous
NFAT5 in the indicated cell lines were resolved in SDS-polyacrylamide (6%) gels. HA-tagged NFAT5c and NFAT5a constructs were detected by
Western blot with the HA-specific antibody 12CA5, and endogenous NFAT5 was detected with an antibody specific for carboxy-terminal peptide
conserved in all isoforms. A detailed description of this experiment is included in Materials and Methods. (B) Confocal microscopy images of mitotic
and interphase HEK293 cells expressing full-length NFAT5c (FL5c), a mutant lacking its CTD (ND5c) or a mutant lacking the CTD and unable to bind
DNA (ND5c
DB1). Cells transfected with a construct of NFAT5a lacking the CTD (ND5) were analyzed in the same experiment for comparison. Cells were
cultured in isotonic medium (290 and 310 mOsm/kg) or exposed to hypertonic conditions (470 mOsm/kg) during 4 hours. Scale bar is 20 mm. Results
shown are representative of four independent transfections (see Figure S4).
doi:10.1371/journal.pone.0007036.g007
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PLoS ONE | www.plosone.org 10 September 2009 | Volume 4 | Issue 9 | e7036Figure 8. Effect of different regions of the CTD on the exclusion of NFAT5a from mitotic chromatin. Representative confocal microscopy
images of mitotic cells in asynchronous cultures of HEK293 cells expressing the indicated GFP-tagged NFAT5a constructs and cultured in isotonic
conditions (310 mOsm/kg). Scale bar is 20 mm. The results shown are representative of three independent experiments.
doi:10.1371/journal.pone.0007036.g008
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hand, the significance of a complex control of NFAT5 subcellular
localization in isotonic conditions might be found outside
hypertonic stress responses, since this factor can also regulate
osmotic stress-unrelated processes, such as integrin-induced
migration, cell differentiation and viral replication [13–16].
The sustained association of NFAT5 with chromatin through
mitosis and interphase caused by deletion of its CTD was
consistent with the high stability of NFAT5-DNA complexes
described previously in vitro [6]. In this regard, NFAT5 has lower
affinity for DNA than the calcineurin-regulated NFATc proteins,
but NFAT5-DNA complexes are more stable than NFATc-DNA
ones [6]. NFAT5 and NFATc proteins can bind to the same core
GGAAA element [3,34] and, although the number of sites that
could recruit either type of factor in the context of in vivo
chromatin is probably limited, a deregulated NFAT5 that bound
to DNA in mitosis and remained bound to it through interphase
could hinder the access of NFATc proteins to certain sites.
Although other Rel proteins are not known to be regulated by
similar mechanisms, the inhibitory effect of the carboxy-terminal
domain of NFAT5 might recall the ability of the IkB-like carboxy-
terminal regions of the NF-kB proteins p100 and p105 to inhibit
their binding to DNA [35–38]. However, there is no obvious
homology between the carboxy-terminal domain of NFAT5 and
IkBs other than their overall acidic nature. In this regard, NFAT5
does not contain the characteristic ankyrin repeats of IkB proteins,
nor it is proteolyzed during activation. In addition, these IkB-like
domains prevent the activation of NF-kB in interphase in the
absence of specific stimuli, whereas the carboxy-terminal domain
of NFAT5 is inhibitory only in mitosis, and independently of
whether NFAT5-activating conditions are present or not.
We observed an extensive overlapping of NFAT5 regions that
caused its exclusion from mitotic chromatin (amino acids 547–838
and 839–1377 in NFAT5a) with those previously shown to induce
its transcriptional activity (amino acids 960–1397) or enhance it
(amino acids 539–876) [18] (Figure 11A). A relevant question is
how these regions can switch NFAT5 from a transcriptionally
active state, in which NFAT5 must be bound to chromatin, to
another in which it is excluded from DNA. It can be proposed that
mitosis-specific modifications of either NFAT5 or the chromatin,
or a repressor protein interacting with NFAT5 in mitosis might
disrupt the binding of this factor to DNA. On the other hand, the
CTD of NFAT5 has a high content of serines (145 residues) and
threonines (74 residues), which together comprise more than 22%
Figure 9. Transcriptional activity of NFAT5a CTD mutants. NFAT5-deficient MEF cotransfected with the indicated constructs and the ORE-Luc
reporter were cultured in isotonic medium (310 mOsm/kg) or exposed to hypertonic conditions (510 mOsm/kg) during 20 hours. The activity of each
construct is represented as relative to that of DBD5 (transcriptionally inactive) in cells cultured in isotonic medium (arbitrary value of 1). Results are
the mean6SD of three independent experiments.
doi:10.1371/journal.pone.0007036.g009
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ylation-dependent regulation. The observation that different parts
of the CTD of NFAT5 could independently inhibit its binding to
mitotic chromatin also raises the question of whether these regions
share a common feature or instead each of them uses a different
mechanism. However, these regions do not display obvious
sequence similarities between them, nor with other proteins
known to be excluded from mitotic DNA, such as the C2H2 zinc
finger or the POU families of transcription factors [25–27].
Besides these questions, it remains to be known whether
transactivation domains in other proteins can also play a dual
role as activators of transcription in interphase and repressors of
DNA-binding in mitosis, and whether they can reset the nucleo-
cytoplasmic localization of transcription factors by controlling
their association with mitotic chromatin.
Materials and Methods
Cell lines, hypertonicity treatment, cell cycle arrest
The human embryonic kidney cell line (HEK293), the
osteosarcoma-derived U2OS cell line (American Type Culture
Collection), the human cervix adenocarcinoma HeLa cell line, and
NFAT5
2/2 mouse embryonic fibroblasts (MEF) [9], were grown
in Dulbecco’s Modified Eagle’s Medium (DMEM) (Gibco)
supplemented with 10% fetal bovine serum (Gibco), 2 mM L-
glutamine (Gibco), 50 mM beta-mercaptoethanol (Gibco), 1 mM
sodium pyruvate (Gibco) and the antibiotics penicillin (100 units/
ml) and streptomycin (100 mg/ml) (Gibco) (complete medium).
This culture medium was made hypertonic, as indicated in figure
legends, by addition of NaCl from an sterile 5 M stock solution.
Osmolality was measured with a vapor pressure osmometer
(VAPRO 5520 from Wescor). For the G1 arrest experiments,
HEK293 or U2OS cells were switched to complete media with
2 mM 2-hydroxyurea (Calbiochem) immediately after transfection
and cultured during 48 hours. G1 arrest was confirmed by flow
cytometry analysis in cells labeled with 5 mg/ml of the DNA
dye Hoechst 33342 (Sigma-Aldrich) during the last hour of
culture. Cells were analyzed using a BD-LSR cytometer
(Becton Dickinson) and the Cellquest software V3.3 (Becton
Dickinson).
Fluorescence microscopy
HEK293 cells transfected with different GFP-fusion constructs
(described below) were cultured for 48 hours on sterile glass
coverslips coated with either polylysine (Sigma-Aldrich, 0.01% w/
v in water) or collagen (Sigma-Aldrich, 0.005% in 0.02 N acetic
acid). Cells were fixed with 3% paraformaldehyde in 0.1 M
Phosphate buffer pH 7.4, washed three times with 0.5% NP-40 in
PBS, and stained with propidium iodide (Sigma-Aldrich, 30 mg/
ml in 0.03% Sodium Citrate solution) for 30 min at 37uC or with
2 mM TO-PRO3 iodide (Invitrogen) for 30 min at room
temperature. For U2OS cells, the process was similar but cells
were plated directly on top of sterile glass coverslips. Cells were
visualized by confocal laser microscopy (Leica TCS SP2) and
images were acquired using the Leica Confocal Software v.2.6.1
Build 1537. Optical section thickness was fixed to 400 nm. For the
detection of endogenous NFAT5, HEK293 cells were cultured on
top of collagen-coated (Sigma-Aldrich) coverslips for 48 hours.
After that, hypertonic stimulation was done for 4 and 6 hours, cells
were fixed with 3% paraformaldehyde, and stained with a
previously described rabbit polyclonal anti-NFAT5 antibody
specific for its DNA binding domain [3]. DNA was stained with
2 mM TO-PRO3 iodide as indicated above, and cells were
visualized by confocal laser microscopy.
Transfection of cell lines
HEK293 cells were plated onto 35 mm (9.4 cm
2) tissue culture
dishes at 0.2610
6 cells in 2 ml of culture media. 20 hours after
that, cells were transfected by a calcium phosphate protocol [39]
using 2 to 6 mg of different NFAT5 expression vectors (as in-
dicated) and an empty plasmid (pCMV-HA vector, Clontech) to
normalize for the total amount of transfected DNA. NFAT5
2/2
MEF cells were plated onto 35 mm tissue culture dishes at
0.7610
5 cells in 2 ml of media. 20 hours after that, cells were
transfected by calcium phosphate using 450 ng of the ORE-Luc
reporter plasmid [9], 600 ng of TK-Renilla plasmid (Promega),
1.25 to 2.5 mg of the different NFAT5 expression vectors and an
empty plasmid (pCMV-HA plasmid) used to adjust the final
amount of transfected DNA to 6 mg.
Reporter assays
NFAT5
2/2 MEF were transfected as indicated above. 12 hours
later, transfection was stopped by renewing the complete media.
20 hours after that, cells were left untreated (310 mOsm/Kg) or
stimulated with 510 mOsm/Kg for another 20 hours. After that, cells
were lysed using Passive Lysis Buffer (Promega) and the Luciferase
and Renilla activities were measured using the Dual-luciferase
reporter system (Promega) withaB e r t h o l dF B 1 2luminometer
(Berthold). Luciferase activity was normalized to Renilla.
Cell lysis, chromatin fractionation, immunoblot assays
and antibodies
To isolate soluble and chromatin fractions, HEK293 cells were
resuspended (6610
6 cells/ml) in buffer A (10 mM HEPES,
pH 7.9, 10 mM KCl, 1.5 mM MgCl2, 0.34 M sucrose, 10%
glycerol, 1 mM iodoacetamide, 5 mg/ml leupeptin, 5 mg/ml
aprotinin, 1 mg/ml pepstatin A, 10 mM beta-glycerophosphate,
1 mM PMSF, 10 mM NaF, 10 mM sodium orthovanadate) (as
described in [40]). Next, Triton X-100 (0.1%) was added, and cells
were incubated for 15 minutes on ice. Nuclei were collected by
low-speed centrifugation (at 1,300 g, 4uC for 4 min), and the
supernatant was separated for protein quantification and boiled
in reducing 1x Laemmli buffer for 10 min at 100uC. Nuclei were
washed twice in buffer A, and then were either boiled in
Figure 10. Comparison of the transcriptional activity of wild-
type NFAT5a and a constitutively nuclear mutant in isotonic
and hypertonic conditions. NFAT5-deficient MEF were cotransfected
with a constant amount of the ORE-Luc reporter plus different
concentrations of expression vectors (1.5 to 6 mg of DNA/9.4 cm
2-well)
encoding wild-type NFAT5a (FL5), a constitutively nuclear mutant
(FL5
AED) or an inactive DNA binding mutant (FL5
DB1), and then were
cultured in isotonic medium (290 mOsm/kg) or exposed to hypertonic
conditions (510 mOsm/kg) during 20 hours. The activity of each
construct is represented as relative to that of 1.5 mg of FL5 in isotonic
medium (arbitrary value of 1). Results are the mean6SEM of four
independent experiments (* p,0.05).
doi:10.1371/journal.pone.0007036.g010
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incubated in buffer A plus DNase I (Worthington, 0.2 mg/ml,
25uC, 15 min) to extract chromatin-associated proteins
(Figure 5C). Samples containing proteins released from chromatin
were centrifuged (13,000 g, 4uC, 10 min) to sediment debris and
the supernatants were boiled for 10 min at 100uC in 1x Laemmli
reducing buffer. Whole cell extracts were done using buffer A plus
0.1% Triton X-100 supplemented with DNase I (Worthington,
0.2 mg/ml). For Western blotting, lysates were subjected to SDS-
polyacrylamide gel electrophoresis and transferred to PROTRAN
(BA-83, Schleider & Schuell) membranes in 25 mM Tris, pH 8.4,
192 mM glycine and 20% methanol. After blocking the
membranes with 5% dry milk in 1xTBS, the following antibodies
were used: rabbit polyclonal NFAT5-specific antibody raised
against a carboxy-terminal peptide (Affinity Bioreagents), mouse
monoclonal antibody to Myc (9E10), mouse monoclonal antibody
to GFP (Covance), goat antibody to pyruvate kinase (Chemicon) or
rabbit polyclonal antibody to histone H3 (Abcam). The antibody
to rabbit IgG coupled to HRP was from Promega, the antibody to
mouse IgG coupled to HRP was from Amershan, and the
antibody to goat IgG coupled to HRP was from DAKO. Protein
bands were visualized by enhanced chemiluminescence, using
ECL Western Blotting Detection Reagent (Amershan).
Intracellular detection of phosphorylated Ser10 of
Histone H3
Asynchronously growing HEK293 cells were labelled following
an intracellular staining protocol previously described [41]. Briefly,
cells were fixed in 1.5% paraformaldehyde (Sigma-Aldrich) in PBS
on ice for 15 minutes, and permeabilized with 70% ethanol at
Figure 11. (A) Schematic representation of NFAT5a exons and functional regions in its CTD. Regions causing a strong exclusion from mitotic chromatin
are indicated with black boxes and those with a weaker effect are shown in white boxes. Modulatory and activation domains characterized previously
[18] are shown as hatched grey or black boxes, respectively. (B) Model illustrating the regulation of NFAT5 nucleo-cytoplasmic localization by its
exclusion from mitotic chromatin. During interphase, the access of NFAT5 to target sites in chromatin is controlled by stimulus-regulated translocation
across the nuclear pore. Nuclear envelope breakdown in mitosis makes DNA potentially accessible to the DBD of NFAT5. The carboxy-terminal domain
inhibits the binding of NFAT5 to mitotic chromatin, contributing to localize NFAT5 in the cytosol after the nuclear envelope is formed in the next
interphase. Hypertonicity reactivates translocation and association with DNA target sites. Disruption of mitotic exclusion of NFAT5 would lead to its
constitutive nuclear localization and association with chromatin in the next interphase without hypertonic stimulation.
doi:10.1371/journal.pone.0007036.g011
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tion and two washes with BTP Buffer (1% BSA, 0.2% Triton-X, in
1X PBS), and cells were incubated with rabbit polyclonal anti-
phospho-histone H3 (Upstate-Millipore) (1 mg/10
6 cells) for
2 hours. Bound primary antibodies were detected by incubating
the cells with PE-labelled secondary antibodies (Sigma-Aldrich) for
1 hour at room temperature. DNA was then stained using 5 mg/
ml Hoechst 33342 for 30 minutes at room temperature.
Constructs
Full-length human NFAT5a tagged with 6 copies of a Myc
epitope (Met-Glu-Gln-Lys-Leu-Ile-Ser-Glu-Glu-Asp-Leu-Asn-Glu)
in its amino-terminal and the enhanced green fluorescence protein
(GFP) at its carboxy-terminal (Myc-NFAT5-GFP); a truncated
NFAT5a comprising the amino-terminal and the DNA-binding
domain tagged with 6 copies of the Myc epitope in its amino-
terminus and the enhanced green fluorescence protein (GFP) at its
carboxy-terminus (Myc-ND5-GFP); the DNA-binding domain of
NFAT5a(DBD5)taggedwithanaminoterminal GFP and amutant
DBD5 with T222A, E223A and R226A substitutions that cannot
bind DNA (DBD5
DB1), have been described elsewhere [3,5]. The
full length NFAT5a construct tagged with 3 copies of an hem-
agglutinin (HA) epitope in its amino terminus has been described
[5]. A detailed description of the respective mutagenesis and
subcloning steps follows. Unless specified otherwise, the template
used was the NFAT5a expression vector Myc-NFAT5-GFP
described in [3], corresponding to human NFAT5a (GenBank
accession number: AF134870), and all the constructs had an amino-
terminal tag with 6 copies of a Myc epitope and a carboxy-terminal
GFP tag. All constructs newly generated for this study were verified
by sequencing.
Mutants NFAT5
12547, NFAT5
12838, NFAT5
121221, and
NFAT5
121377:
NFAT5
12547: PCR with primers 59 TGG AAG ATC TCA
TGA TGT TCA ACC ATT CAC 39 and 59 ACA CCG GTC
CCT TAA AAA TAG TGG ACG ATC TTT TTT CTGC 39
was done to amplifying a region from nucleotides 1362 to 1641 in
the cDNA of human NFAT5a. The PCR product and the NFAT5
expression vector (Myc-NFAT5-GFP) were digested with BglII
and AgeI restriction enzymes. The region amplified was subcloned
into the expression vector. The resulting construct comprises the
amino-terminal and DNA-binding domains plus a fragment of the
carboxy-terminal domain comprising amino acids 473 to 547. A
silent point mutation at position 1626 in the cDNA of NFAT5 was
introduced to disrupt a second restriction site for BglII.
NFAT5
12838: PCR with primers 59 CAG TCT AGA GAG
ATA TTA CAG TCA GATG 39 and 59 ACA CCG GTC CCT
CTG ACT GAA TCT GGG CAG 39 was done to amplifying a
region from nucleotides 1924 to 2514 in the cDNA of human
NFAT5a. The PCR product and the NFAT5 expression vector
(Myc-NFAT5-GFP) were digested with XbaI and AgeI restriction
enzymes. The region amplified was subcloned into the expression
vector. The resulting construct comprises the amino-terminal and
DNA-binding domains plus a fragment of the carboxy-terminal
domain comprising amino acids 473 to 838.
NFAT5
121221: PCR with primers 59 CAG TCT AGA GAG
ATA TTA CAG TCA GATG 39 and 59 ACA CCG GTC CCA
TGT TTG GTG GTG GTT GCT 39 was done to amplifying a
region from nucleotides 1924 to 3639 in the cDNA of human
NFAT5. The PCR product and the NFAT5a expression vector
(Myc-NFAT5-GFP) were digested with XbaI and AgeI restriction
enzymes. The region amplified was subcloned into the expression
vector. The resulting construct comprises the amino-terminal and
DNA-binding domains plus a fragment of the carboxy-terminal
domain comprising amino acids 473 to 1221.
NFAT5
121377: PCR with primers 59 CAG TCT AGA GAG
ATA TTA CAG TCA GATG 39 and 59 ACA CCG GTC CAT
TTT GAA TGC CAA ATA AGA 39 was done to amplifying a
region from nucleotides 1924 to 4131 in the cDNA of human
NFAT5a. The PCR product and the NFAT5 expression vector
(Myc-NFAT5-GFP) were digested with XbaI and AgeI restriction
enzymes. The region amplified was subcloned into the expression
vector. The resulting construct comprises the amino-terminal and
DNA-binding domains plus a fragment of the carboxy-terminal
domain comprising amino acids 473 to 1377.
Mutants NFAT5
12497, NFAT5
(12547)+(137821455),
NFAT5
(12497)+(137821455), NFAT5
(12473)+(83921377),
NFAT5
(12473)+(83921455), DBDC5, ND5
DB1, FL5
DB1: These mu-
tants correspond to deletion or substitutions. They were done
using the QuickChange XL Site-directed mutagenesis system
(Stratagene).
NFAT5
12497 was done using the NFAT5
12547 expression
vector as a template and the set of primers 59 GAA GAG GCC
ATG AAA GCA GGC GCC ATG GTG AGC AAG GGC 39 and
59 GCC CTT GCT CAC CAT GGC GCC TGC TTT CAT
GGC CTC TTC 39. The resulting construct comprises the amino-
terminal and DNA-binding domains plus a fragment of the
carboxy-terminal domain comprising amino acids 473 to 497.
NFAT5
(12547)+(137821455) was done using the Myc-NFAT5-GFP
expression vector as a template and the set of primers 59 CTT
CCA CTA TTT TTA AGG GCG AAG GTA ACT GTA GTC
AGC TT 39 and 59 AAG CTG ACT ACA GTT ACC TTC GCC
CTT AAA AAT AGT GGA AG 39. The resulting construct
comprises the amino-terminal and DNA-binding domains plus a
fragment of the carboxy-terminal domain comprising amino acids
473 to 547 and amino acids 1378 to 1455.
NFAT5
(12497)+(137821455) was done using the Myc-NFAT5-GFP
expression vector as a template and the set of primers 59 AGA
GGC CAT GAA AGG CGA AGG TAA CTG TAG TCA G 39
and 59 CTG ACT ACA GTT ACC TTC GCC TTT CAT GGC
CTC T 39. The resulting construct comprises the amino-terminal
and DNA-binding domains plus a fragment of the carboxy-
terminal domain comprising amino acids 473 to 497 and amino
acids 1378 to 1455.
NFAT5
(12473)+(83921377) was done using the NFAT5
121377
expression vector (described above) as a template and the set of
primers 59 CAG ACC CAG CAG CAG CTG GTT TAT TCC
CTT CAA CTG CTT C 39 and 59 GAA GCA GTT GAA GGG
AAT AAA CCA GCT GCT GCT GGG TCT G 39. The
resulting construct comprises the amino-terminal and DNA-
binding domains plus a fragment of the carboxy-terminal domain
comprising amino acids 839 to 1377.
NFAT5
(12473)+(83921455) was done using the Myc-NFAT5-GFP
expression vector as a template and the set of primers 59 CAG
ACC CAG CAG CAG CTG GTT TAT TCC CTT CAA CTG
CTT C 39 and 59 GAA GCA GTT GAA GGG AAT AAA CCA
GCT GCT GCT GGG TCT G 39. The resulting construct
comprises the amino-terminal and DNA-binding domains plus a
fragment of the carboxy-terminal domain comprising amino acids
839 to 1455.
FL5
DB1 and ND5
DB1. Alanine substitutions in positions T222,
E223, and R226 were introduced using the Myc-NFAT5-GFP or
Myc-ND5-GFP expression vectors as a templates, respectively,
and the set of primers 59 GAG CTC GGT ACC TGG CTG
CGG GCA GCG CTG GGT CAG TGA AAG 39 and 59 CTT
TCA CTG ACC CAG CGC TGC CCG CAG CCA GGT ACC
GAG CTC 39.
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vector as a template and the set of primers 59 GGC CCC ATG
GGC GGT AAT GGA ACA TTG GAA AAC C 39 and 59 GGT
TTT CCA ATG TTC CAT TAC CGC CCA TGG GGC C 39.
The resulting construct comprises the DNA-binding- and carboxy-
terminal domains (amino acids 175 to 1455).
Myc-FL5
NLS-GFP and Myc-ND5
NLS-GFP were done using
Myc-full length NFAT5-GFP or Myc-ND5-GFP, respectively, as
templates, and point mutations were introduced to change amino
acids RKR (positions 126 to 128 in NFAT5a) to AAA, as
described [20]. The primers used were 59 CCT CGT AAA TCA
GCT GCA GCA AAT CCA AAG CAG39 and 59 CTG CTT
TGG ATT TGC TGC AGC TGA TTT ACG AGG 39.
Myc-FL5
AED-GFP and Myc-ND5
AED-GFP were done using the
Myc-full length NFAT5-GFP or Myc-ND5-GFP, respectively, as
templates and the set of primers 59 CAG TAA CAC AGT TCA
GCA GAT GTC CTG CCA GGA TGA G 39 and 59 CTC ATC
CTG GCA GGA CAT CTG CTG AAC TGT GTT ACT G 39.
An internal deletion was done (from amino acids 56 to 80 in
NFAT5a), as described [20]. The same strategy was used to
generate the double mutant NLS plus AED in FL5 or ND5 using
the FL5
NLS and ND5
NLS mutants as templates.
NFAT5c isoform constructs. A cDNA vector for human
NFAT5 isoform c (NCBI reference NP_006590.1) was kindly
provided by Osamu Ohara (Kazusa DNA Research Institute,
Japan) [42]. NFAT5c was subcloned in the pEGFP-N1 vector and
tagged with 3 copies of an hemagglutinin (HA) epitope in its amino
terminus. Two versions of this construct were generated, one with
a GFP tag in frame at its carboxy terminus (HA-NFAT5c-GFP)
and another without GFP (HA-NFAT5c). The ND5c construct
contained the amino-terminal and DNA binding domains of
NFAT5c and was generated by subcloning to replace the Myc
epitopes and amino-terminal region of Myc-ND5-GFP with a
fragment encoding the HA epitopes and the amino-terminal
region from HA-NFAT5c. The resulting NFAT5c construct had 3
copies of an HA epitope in its amino terminus and one GFP in
frame after its DNA binding domain. The same subcloning
strategy was used to generate ND5c
DB1 in the Myc-ND5
DB1-GFP
backbone.
Comparison of the relative mass of recombinant NFAT5a
and NFAT5c isoforms with endogenous NFAT5
Lysates of HEK293 cells transfected with vectors encoding
either NFAT5a or NFAT5c tagged with 3 copies of an HA epitope
in their amino termini were run in the same SDS-polyacrylamide
(6%) gel in parallel with lysates of several untransfected human cell
lines (HEK293, U2OS and HeLa) or mouse embryonic fibroblasts
(MEFs). In a first approach, gels were transferred to nitrocellulose
membranes and probed sequentially with an anti-HA mouse
monoclonal antibody (12CA5) followed by a rabbit antibody (anti-
NFAT5) specific for a carboxy-terminal peptide common to all
NFAT5 isoforms (Affinity Bioreagents). However, the anti-
NFAT5, which detected endogenous NFAT5 also in the
transfected HEK293 samples, gave a much stronger signal than
the anti-HA antibody and obscured the detection of the band
corresponding to the transfected HA-tagged constructs in the same
lanes. This problem occurred regardless of the order in which
antibodies were used for Western blotting. To solve this, we added
a lane with molecular weight markers between the samples of
transfected and untransfected cells and used it as a guide to slice
the membrane along the vertical axis. Lysates from transfected
HEK293 cells were used for HA detection and contained an
amount of lysate equivalent to 0.36610
6 cells/lane, whereas
lysates from untransfected cell lines for detection of endogenous
NFAT5 had 0.18610
6 cells/lane. Both halves of the membrane
were probed separately with anti-HA or anti-NFAT5 antibodies
respectively and, before developing them by ECL, were realigned
following the markers of the sliced lane.
Statistical Analysis
Mean, standard deviation (SD), standard error of the mean
(SEM) and statistical significance (t-Student test) were calculated
using Microsoft Excel software.
Supporting Information
Figure S1 Association of NFAT5a mutants with mitotic
chromatin. Confocal microscopy images of mitotic HEK293 and
U2OS cells expressing the indicated GFP-tagged constructs in
isotonic conditions (310 mOsm/kg) or after a 6-hour exposure to
hypertonic conditions (470 mOsm/kg). Scale bar is 20 A ˆmm.
Found at: doi:10.1371/journal.pone.0007036.s001 (4.33 MB TIF)
Figure S2 Effect of the CTD and DNA binding on the
subcellular distribution of NFAT5a constructs in interphase. (A)
GFP-tagged constructs FL5, ND5 or DBD5 were expressed in
U2OS cells. Their subcellular distribution in interphase in isotonic
(310 mOsm/kg) and hypertonic conditions (470 mOsm/kg,
4 hours) was analyzed by confocal microscopy. Scale bar is
20 mm. Images are representative of three independent experi-
ments. (B) HEK293 cells (left panel) or U2OS cells (right panel)
expressing GFP-tagged NFAT5 DNA-binding domain (DBD5) or
its DNA-binding mutant DBD5DB1 were cultured in isotonic
medium (310 mOsm/kg) or exposed to hypertonic conditions
(470 mOsm/kg) during 6 hours, then fixed and analyzed by
confocal microscopy. Scale bar is 20 mm. The results shown are
representative of four independent experiments.
Found at: doi:10.1371/journal.pone.0007036.s002 (2.34 MB TIF)
Figure S3 Effect of the nuclear localization signal (NLS) and the
auxiliary export domain (AED) on the association with mitotic
chromatin of an NFAT5a mutant lacking its CTD. Association of
the indicated ND5 constructs with mitotic chromatin in isotonic
conditions (310 mOsm/kg). Scale bar is 20 A ˆmm. Results shown
are representative of three independent transfections.
Found at: doi:10.1371/journal.pone.0007036.s003 (2.52 MB TIF)
Figure S4 Comparison of the subcellular localization of
NFAT5a and NFAT5c CTD deletion mutants. Summary of
subcellular localization analyses of the indicated NFAT5 con-
structs in interphase HEK293 cells cultured in isotonic medium
(290 and 310 mOsm/kg) or exposed to hypertonic conditions
(470 mOsm/kg, 4 hours). At least 50 cells with similar GFP
fluorescence intensity were counted for each transfected construct
in each transfection. Results are the mean6SEM of four
independent experiments.
Found at: doi:10.1371/journal.pone.0007036.s004 (0.32 MB TIF)
Figure S5 Schematic representation of NFAT5a constructs
corresponding to deletions in the CTD. Constructs were tagged
with 6 copies of a Myc epitope at their amino terminus and GFP at
their carboxy terminus. Western blots were done with anti-Myc
antibody in lysates from HEK293 cells transfected with the
indicated constructs.
Found at: doi:10.1371/journal.pone.0007036.s005 (1.12 MB TIF)
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